Additional information
White powder
1402053-59-1
ACI-036414
145.9-148.8°C
C14H20N2O4
280.32
Ambient
2-8°C
Neurodegenerative
Pharmaceutical Impurity Standards
(S)-methyl 2-(2-(propan-2-ylidene)hydrazinyl)-2-(3,4-dihydroxybenzyl)propanoate
(S)-methyl 2-(2-(propan-2-ylidene)hydrazinyl)-2-(3,4-dihydroxybenzyl)propanoate
Benzenepropanoic acid, 3,4-dihydroxy-?-methyl-?-[2-(1-methylethyl)diazenyl]-, methyl ester, (?S)





![N-BOC-N-DESHYDROXYETHYL DASATINIB (25 mg) (2-Methyl-2-propanyl 4-[6-({5-[(2-chloro-6-methylphenyl)carbamoyl]-1,3-thiazol-2-yl}amino)-2-methyl-4-pyrimidinyl]-1-piperazinecarboxylate )](https://analyticachemie.in/ver-2/wp-content/uploads/uspimage-1.jpg)